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AbstrAct
Objective To provide a framework that is able to 
categorise whether patients are able to adapt to and lead 
a ‘normal’ life with ulcerative colitis (UC) and to detail the 
factors that influence this.
Design Qualitative research study using in-depth semi-
structured interviews.
setting Four clinical sites in the West and East Midlands 
regions of England.
Participants 28 adult patients diagnosed with UC for 
years between 1 and 22.
results Medication was rarely sufficient for patients to 
adapt to UC and live as ‘normal’ a life as possible. Virtually 
all patients tested and adopted non-medical adaptation 
methods to improve physical and psychological well-
being, to help them carry on working and to prevent 
embarrassment. In addition, some patients benefited from 
outside support providing them with practical, emotional 
and/or financial help. In conjunction with adaptation 
strategies and the time to adapt, this meant that some 
patients with severe clinical disease were able to maintain 
a sense of normality in life. Patients reported that clinicians 
were not always receptive to discussion of the broader 
context of life with UC.
conclusions Patients’ experience of UC and their ability 
to adapt in order to maintain a sense of normality in life 
is a complex interplay of symptoms, adaptation strategies 
and outside support. Over time patients test out a variety 
of non-medical adaptation strategies. Awareness of 
this may help clinicians and researchers to understand 
patients’ views on the role of medical and other therapies. 
Further research around the utility of this framework in 
clinical practice and research is now required.
trial registration number ISRCTN56523019, results.
IntrODuctIOn
Ulcerative colitis (UC) is a form of chronic 
inflammatory bowel disease (IBD), which 
affects the large bowel. Over 1 45 000 people 
in the UK1 and 9 00 000 people in the USA2 are 
living with UC. The condition is most preva-
lent in Northern Europe and North America, 
although the number of people affected 
by UC is increasing recently in developing 
countries.3 There is also an increasing inci-
dence of UC among younger patients.4 
Around 40% of patients will experience a 
relapse annually, with between 20% and 30% 
requiring total colectomy in their lifetime.5 6 
Reducing relapse rates and disease progres-
sion is a priority for patients.7Ulcerative 
colitis has been shown to have a significant 
negative impact on health-related quality of 
life (HRQoL).8While many patients’ lives are 
severely disrupted as, for example, the disease 
affects their ability to work as well as their 
social and family life,8–11 these impacts are 
not always directly correlated, from a clinical 
perspective, with disease activity and severity 
of symptoms.12Patients with mild clinical 
disease can experience significant impacts on 
HRQoL and psychological morbidity, while 
some with apparently severe disease activity 
seem to ‘cope’ relatively well.
Commentators have argued that often the 
focus of the medical management of IBD is 
too much on acute episodes, not necessarily 
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Research
strengths and limitations of this study
 ► This study is an in-depth participant-focused 
qualitative study providing rich and detailed 
accounts of patients’ experiences of living with and 
adapting to ulcerative colitis (UC).
 ► This is the first detailed analysis that has attempted 
to categorise whether patients are able to adapt to 
and lead a ‘normal’ life with UC and also to detail the 
factors that influence this.
 ► The semi-structured interviews provided patients 
the opportunity to talk about their experience to 
someone outside of their clinical team.
 ► The research is cross-sectional in nature, limiting 
the potential to observe the temporal components of 
adaptation over time.
 ► The patients interviewed were participating in a pilot 
trial, which means that the range of patients was 
influenced by the trial eligibility criteria.
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reflecting the chronicity of IBD and therefore the overall 
patient experience of disease over time.13 Understanding 
more about living with IBD can help to highlight the 
role that medical and surgical management plays. The 
patient’s perspective on living with UC may sometimes be 
difficult for clinicians to interpret as they may underesti-
mate or overlook the overall effects of disease on patients’ 
lives.8
Qualitative research is well placed to describe and 
understand patients’ views on disease and treatment.14 
Within IBD and UC, there is a small but informative 
body of qualitative research relevant to these issues and 
work to date has described patients’ perspectives on the 
impact of IBD; of the physical symptoms and broader 
issues, for example, on work, lifestyle, daily activi-
ties, social life and psychological well-being.8–11 15–20 
Research has suggested that patients are engaged in 
a ‘fight’ for some sort of health-related normality and 
that achieving a ‘new normal’ is their ultimate goal.15 
Trying to live as ‘normal’ a life as possible is something 
that patients reflect on when they talk about life with 
IBD.12 This body of research describes patients’ views 
on how their lives are affected by IBD and shows that 
adaptation (ie, a desire for normality) is an overriding 
concern. However, to date nobody has provided a clear 
framework to help understand normality and adapta-
tion in UC.
The aim of this paper is therefore twofold: (1) to 
provide a framework that is able to categorise whether 
patients are able to adapt to and lead a ‘normal’ life with 
UC and (2) to detail the factors that influence this.
MethODs
Setting and study design
Participants were recruited from four hospitals in the 
West and East Midland regions of England and were 
taking part in the National Institute for Health Research 
(NIHR) for Patient Benefit-funded ACCURE-UK trial.21 
This randomised external pilot trial was exploring the 
feasibility of a multi-centre randomised controlled trial 
(RCT) of therapeutic appendicectomy for the treatment 
of UC (intervention arm) in addition to standardised 
medical therapy (control arm). The trial included inte-
grated qualitative research, the main aim of which was to 
investigate the acceptability of the trial and understand 
this within the context of patients’ everyday lives with 
UC.
The theoretical underpinnings of our approach most 
closely align with interpretive description. Originally 
described in nursing and drawing on methods from 
established qualitative methodologies, this approach 
has a heavy emphasis on understanding and informing 
clinical practice.22 23 The research methods we describe 
(eg, for interviews—broad purposive sampling, iterative 
in-depth data collection and inductive analysis without 
a priori theoretical tools) are concordant with a generic 
interpretive approach to addressing our research aims.
sampling and recruitment
We recruited a diverse sample (age, gender, time since 
diagnosis) of patients from both arms of the pilot RCT. 
Clinical staff initially discussed the qualitative research 
with patients. With consent, the contact details of patients 
expressing an interest were passed to the researcher 
conducting the interviews (CM), who then took informed 
consent prior to interview.
Data collection
Semi-structured one-to-one interviews were conducted 
by CM between randomisation and surgery for those 
allocated to intervention arm, and shortly after randomi-
sation for those in the control arm.  CM is a non-clinical 
trained qualitative researcher independent from partici-
pants’ clinical care and the day-to-day trial management. 
This was clearly communicated to participants. Partici-
pants were asked to select a convenient time and place 
for interview. Most chose to be interviewed at home, 
although a small number of interviews were conducted 
on hospital or university premises, or by telephone.
The interview schedule was informed by the existing 
literature and consultation with the wider research team. 
It included discussion of patients’ views and experience 
of life with UC since initial diagnosis: their symptoms, 
their flare ups and their impacts, their medical treatment 
and their perspectives on adaptation to UC. In addition, a 
section of the interview focused on participants’ perspec-
tives on the RCT and trial processes (data not reported 
here). Interviews were conducted in a participant-focused 
open-ended manner. After initial piloting, data collection 
and analysis took place iteratively. This continued until 
the research team judged that the data and sample had 
sufficient depth and breadth to address initial research 
questions.24 Field notes were kept after the interviews to 
record factors that might have influenced the conduct 
and the analysis of the interviews.
Data analysis
All interviews were audio-recorded and transcribed 
verbatim by a specialist external transcription company. 
Data were analysed thematically and managed using 
Computer-Aided Qualitative Data Analysis Software 
(CAQDAS), NVivo10. The analysis was informed by the 
framework analytical approach.25First, interview tran-
scripts were reviewed several times and open coding was 
undertaken. These codes were then reviewed and catego-
rised and the dataset was indexed. Categories were refined 
into overarching themes from descriptive accounts of the 
data. Final analysis and explanation was facilitated by 
use of a typology and associative analysis using charting. 
The analytic typology is described in more detail below. 
A sample of interviews were coded by an independent 
researcher during initial coding. The research team 
ensured not only that code saturation was reached but 
also that we had a deep and rich understanding of what 
the themes derived during analysis were about.26 The 
final analysis and interpretation were discussed among 
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Table 1 Normality types.
Type/category Definition and constituent elements
Non-normal life  ►Some people may find it difficult to accept their condition and attempt to carry on as before, even hiding 
their condition from others. This may have negative consequences when this is not successful
 ►Symptoms may be devastatingly intrusive and unmanageable for some. It may be difficult or impossible 
to carry out day-to-day activities, for example, because of symptoms and/or embarrassment, despite 
acknowledging and trying to adapt to the condition
 ►The condition can threaten peoples’ self-identity and associated sense of normality
 ►There may be a feeling of loss of control over the disease and life
Normal life  ►For some, medication may be so effective that they can carry on as normal that is, as before the diagnosis
 ►Other patients may experience mild symptoms with minimal impact on life, daily activities and self-
identity, with control facilitated by medication
 ►Some patients with more severe symptoms may reconceptualise normal life by including their condition 
and its impacts in a life that accommodates the disease. This will include acceptance of the condition and 
reorientation of self-identity and thoughts about what constitutes a healthy body
Adapted from Sanderson et al.27
the research team, and with one patient who took part in 
the interviews.
Analytic typology
During analysis, we have applied a typology devised 
from qualitative data gathered with patients diagnosed 
with rheumatoid arthritis, another chronic inflamma-
tory disease of relapsing remitting nature.27 A typology 
is a classification system that consists of categories that 
describe different types of a phenomenon of interest, 
here adaptation to life with UC and the ability to attain a 
new sense of normality. Typologies are sometimes used to 
categorise observations in qualitative data.28
In addressing our first research aim, we have catego-
rised participants into two types (see table 1 and table 2), 
one of broadly positive experience and adaptation to 
UC (the normal life) and one of negative experience 
and non-adaptation (the non-normal life). This typology 
encompasses patients’ reactions to their illness, their 
attempts to adapt to it and success or failure in this. Of 
note, these are not static categorisations; patients may 
move between them, over time and as a consequence 
of changing circumstances. We have used the accounts 
given by participants during the interviews to assign them 
to these two broad categories: at the time of the interview 
and at the time points since diagnosis.
results
The following analysis is based on data from interviews 
with 28 patients (table 2), which lasted between 22 and 
58 min; 16 women and 12 men aged between 18 and 
57; 24 of white and 4 of Asian ethnic origin; diagnosed 
with UC between 1 and 22 years. All were in remission 
at the time of interview but had experienced a disease 
relapse within the preceding 12 months (RCT eligibility 
criteria). All but one were on medical therapy, with three 
having taken biologic therapies, such as infliximab and 
adalimumab. One patient had decided to discontinue all 
medical therapy due to side effects. None had undergone 
any colonic surgery previously. There was no withdrawal.
Findings are presented as follows:
 ► the normality types experienced and described by our 
participants;
 ► their adaptation strategies and intended purpose;
 ►  the outside support to adaptation;
 ► how these factors interact with symptoms to influence 
the ability of a patient with UC to lead a normal life.
Participants’ descriptions of normal and non-normal life 
since diagnosis
Our analysis of patients’ accounts suggests that at the 
point of interview, 12 of the 28 participants in this 
sample could be categorised as experiencing some form 
of normal life with UC. There was no clear relationship 
between the length of time since diagnosis and the type 
of normality they were experiencing at the time of the 
interview. At diagnosis, all participants had described 
a period of non-normal life with significant disruption 
due to disease activity and symptoms. Some also talked 
about a need to understand and acknowledge the 
significance of the diagnosis itself. Participants suffered 
from intrusive symptoms (stomach cramps, bleeding, 
more frequent bowel movements); and in many cases, 
it took several months to receive a definitive diagnosis 
and treatment, with several patients ending up being 
admitted to hospital. As a result, they had to take time 
off work and were not able to carry on with their daily 
activities:
Diagnosed in October. We were actually away in Spain 
when I had the flare up, and I was in hospital in Spain 
for a week, and they did all the tests there, then when 
I got back to England they did it all again in October. I 
was due to go in for the camera, and when I got there 
they said that I’d got so weak that they wouldn’t be 
able to do it, but they kept me in, and obviously I was 
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in hospital then for three weeks, or nearly  four weeks 
I believe it was at the time (Patient 18)
Following an initial period of disruption and non-normal 
life around the time of diagnosis participants’ accounts 
vary, with some seemingly not having attained or regained 
any sense of a normal life. Others had managed to do so, 
some temporarily. Only three patients described a period 
where they felt that they had been relatively unaffected 
as their symptoms were largely controlled by medication, 
such that they were able to carry on life without much 
perceived impact. For example, one male participant who 
was diagnosed in 2002 talked about not having a flare up 
while managing UC for the first 5 years with medication. 
None of the participants indicated that medication had 
dealt with all of their symptoms to the extent that life was 
the same as before the onset of disease.
Participants’ descriptions of adaptation strategies and their 
intended purpose
During the interviews, all participants described attempts 
to adapt to their condition, and all but two participants 
actively tested or adopted approaches that were additional 
to medical therapies. We have categorised the adaptation 
strategies described according to their intended purpose. 
Most commonly, participants aimed to achieve four things 
(table 3):
1. To improve physical well-being
2. To improve psychological well-being
3. To carry on working
4. To prevent embarrassment
Improve physical well-being
This category describes participants’ strategies to reduce 
physical symptoms and the frequency of UC flare ups, 
and also to do so by addressing perceived triggers of flare 
ups. The physical symptoms were a very important part 
of the great majority of patients’ accounts, as they made 
them extremely fatigued:
Just draining, not tired, not sleepy, just drained. 
[Name] knows what I’m like, by the time I’ve been 
five times and I’ve just got no energy, just no energy 
to do anything, and I just the best thing is just to give 
into it. I say to [name], you’re going to have to count 
me out for the rest of the day, and just give into it 
(Patient 21)
The most common adaptation approach in this cate-
gory was medication, with all but one participant taking 
regular medication to improve physical well-being. The 
one participant, who had ceased taking medication due 
to side effects, reported that smoking helped to reduce 
symptoms. During the interviews, it was clear that there 
were varied perspectives on whether medication was 
‘working’. Some reported that medication was effective 
and others that it was not. Some participants were unsure 
as to how much it helped:
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Table 3 Adaptation strategies and aims*
Aims of adaptation Adaptation strategies
Improve physical 
well-being (reduce 
symptoms and flare 
ups; prevent triggers of 
flare ups)
 ►Medication
 ►Change diet
 ►Probiotic use
 ►Complementary therapies (eg, acupuncture, hypnotherapy)
 ►Finding a balance between doing too much and too little (pacing)
 ►Exercise
 ►Yoga
 ►Relaxation classes
 ►Smoking
 ►Personal research (including forums, Crohn’s and Colitis UK, social media)
Improving 
psychological well-
being
 ►Positive and proactive attitude
 ►Fighting on/soldiering on in activities (eg, playing netball, going on holiday)
 ►Finding a balance between doing too much and too little (pacing)
 ►Mindfulness courses
 ►Yoga
 ►Relaxation classes
 ►Personal research (including forums, Crohn’s and Colitis UK, social media)
Carry on working  ►Reducing working hours; selling off part of own business
 ►Rearranging working patterns
 ►Changing jobs
 ►Getting up earlier
 ►Finding a balance between doing too much and too little (pacing)
 ►Personal research (including forums, Crohn’s and Colitis UK, social media)
Prevent embarrassment  ►Situational avoidance (not going out; avoiding certain places)
 ►Planning (timing, location, duration of activities)
 ►Wearing nappies
 ►Personal research (including forums, Crohn’s and Colitis UK, social media)
*A number of adaptation methods appear across several categories.
I don’t notice any effect with the anti-inflammatories 
(…) It generally doesn’t keep it [UC] away, because 
like I say I can be fully recovered, go nine/ten 
months of the year whilst taking anti-inflammatories 
every day, and still go into a flare up. But whether if I 
didn’t take them I don’t know if I’d go into a flare up 
quicker. So I don’t know (Patient 1)
Another common adaptation approach to improve 
physical well-being was to change diet. As with other 
adaptation approaches, this was often a trial and error 
strategy with the aim to establish which foods tended to 
worsen symptoms or trigger flares. Some people reported 
keeping a food diary for several weeks or months to iden-
tify patterns in their food intake and symptoms:
When I came out of hospital for about a month I kept 
a list of all the food I’d eaten every day and what I’d 
drank, so that if I went into a flare up I could look 
back and say maybe it was that, so I’ll try it one more 
time and if it happens again I’ll not eat or drink that 
again (Patient 10)
Other adaptation strategies in this category include 
the use of complementary therapies (eg, acupuncture 
or hypnotherapy), exercise, yoga, relaxation courses to 
avoid triggers (stress) and the pacing of activities to find 
a balance between symptoms and the ability to do things.
Improve psychological well-being
When discussing issues pertaining to psychological well-
being, several participants stated that they have a positive 
and proactive outlook on life with UC. We believe that this 
signals acceptance that the disease was not going to go 
away, and describes an associated attitude and approach 
to living with it. This was sometimes evident in discussions 
about the need to ‘soldier on’ and maintain some or all of 
the activities that participants pursued prior to diagnosis, 
such as playing sports, going out and going on holiday. 
Often, similar to other adaptations, this would involve 
a process of testing the boundaries of what was possible 
and finding a balance between the desire to keep going 
and the potential negative (eg, physical) consequences of 
doing too much. For example, Patient 19, a 42-year-old 
woman first diagnosed in 2003 described how, over the 
years, she adapted her activities to have more control of 
her condition, but was keen not to be a ‘victim’, which she 
likened to being ‘too depressive’:
I just refuse to give up and not do anything, and I 
know that the exercise is good for me. But equally 
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I know that doing too much exercise is bad for 
me, because it will make me ill and run down (…) 
refusing to not do anything and be a victim and just 
sit at home doing nothing, because that’s just too 
depressing to even think about isn’t it? (Patient 19)
Specific activities that were adopted by participants in 
an attempt to improve psychological well-being included 
attending mindfulness and relaxation courses, and also 
yoga.
Carry on working
Being able to maintain a working life was expressed as a 
key concern by the majority of our participants. The main 
strategy in order to carry on working was reducing working 
hours, because of fatigue (one of the most commonly 
reported physical symptoms), a lack of concentration and 
the need to constantly be near toilets. Spending less time 
in work meant that participants had more time for them-
selves to rest at home:
There’s certain things I can’t do at work, like I don’t 
do playground duty, because that way I get an extra 
break, I don’t teach PE, it just wears me out really, 
it is quite a physical job. I’ve had to reduce my days 
as well, I did work  three days a week before I was 
diagnosed, and now I only work two (Patient 6)
Participants who reduced their working hours found 
themselves to be more efficient at work. However, this 
had a financial impact, placing burden on participants 
and their families.
Other strategies to maintain working included rear-
ranging working patterns (eg, working only in the 
afternoon as symptoms were worse in the morning; 
spreading working hours throughout the week), changing 
jobs to something less demanding, and getting up earlier 
in the morning to have more time to deal with the symp-
toms and be ready in time for work.
Prevent embarrassment
Avoiding and preventing the embarrassment potentially 
caused by UC was a key theme in the data. This very often 
restricted participants in their daily life, for example, with 
the fear of being embarrassed by not being able to find 
toilets when needed:
I don’t go out as much as I did before, and when I go 
out I’m very nervous, first thing I do a check where 
is the nearest toilet even if I don’t need it, and some 
days if my friends want to go out or do something I 
might be too fatigued (Patient 4)
One strategy employed to prevent embarrassment was 
situational avoidance with some participants reporting 
not going out or not going to places where toilets are not 
readily available. While such avoidance may be perceived 
as being effective in preventing embarrassment, in turn it 
could result in feelings of isolation:
Well because I’ve been having so many flare ups and 
been unwell a lot I don’t have so much of a social life 
now, and every time I try and plan things in I end up 
being ill a lot and having to cancel all the time, so 
I stopped making forward plans now to be honest, 
because if there are things a few months away I just 
say to friends that I have to let you know at the time, 
because I never know what my health is going to be 
like. So it has had quite an impact socially. It can be 
a bit isolating as well, that’s a bit difficult (Patient 8)
Other participants discussed having to carefully plan, 
such as for nights out, around the location of the toilets, 
to limit the frequency of their social outings, or to try to 
plan them during remission periods. Finally, one patient 
reported being able to go out because he was wearing 
nappies, which meant he was not as restricted by the loca-
tion of toilets.
Personal research, including participation in 
disease-specific internet forums and social media, was 
described as contributing to each of the aims associated 
with adaptation strategies that were tested by patients:
It’s just a Facebook group of everybody who has got 
Crohn’s and colitis really, it’s a group where you 
could obviously speak to other people about your 
condition. There’s quite a lot of support on there, 
and it has been mentioned, and so there’s obviously 
people already know already. There seems to be a lot 
of support for anything, awareness of disease, and 
look at ways of improving the condition (Patient 3)
Outside support to adaptation
Some patients spoke about the influence of outside 
support in enabling life and adaptation to UC. Such 
support was not necessarily asked for or actively sought 
by participants but nevertheless helped them live and 
manage UC on a day-to-day basis. They provided an invalu-
able source of social support for several participants.
The main support evident in the data were as follows:
 ► Help from parents/close family members (practical, 
emotional and financial)
 ► Help from a partner and/or children (practical and 
emotional)
 ► Help from friends (practical and emotional)
 ► Help from employer/workplace (practical)
Support from parents and other close family members 
included moving closer to participants or having them 
live with them in order to help with day-to-day tasks, for 
example, the school run, household chores and give 
them financial help:
My parents have moved house to be nearer (…) 
But they rushed the move because I was poorly, they 
actually moved while I was in hospital, because while 
I was in hospital they were staying here for half the 
week to have my boys, because when I was in hospital 
both my boys were preschool age, they were two 
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Figure 1 Influences on normality in ulcerative colitis.
and four, so obviously someone had to have them. 
(Patient 6)
Participants also often discussed the practical and 
emotional support provided by their partners and chil-
dren:
Luckily my daughter is quite mature for her age, 
because she’s only 11, but she does understand, and 
she’s quite good, and she will help me, and if I need 
help she is always there, and make me a cup of tea 
and little things like that. So yes quite lucky in that 
respect. (Patient 15)
Finally, work managers and the workplace often offered 
practical support to patients, mainly by providing flexible 
working hours, helping them to attend hospital appoint-
ments or deal with the impact of symptoms:
Work have been pretty good, been really good with 
allowing me time off for appointments and things. 
(Patient 23)
One patient described how his workplace had recog-
nised UC as a disability, and that this was invaluable in 
providing the means to accommodate the impacts of the 
disease, for example, by taking time off work for hospital 
appointments or because of symptoms.
how symptoms, adaptation strategies and outside support 
interact to influence adaptation and the ability to live a normal 
life with uc
Whether patients are able to maintain or regain a sense of 
a normal life with UC appears to be a complex interplay 
between disease activity and symptoms, the impacts of 
these, attempts to adapt and outside support (figure 1). 
Those patients who, overall, describe and judge their 
disease activity to be mild were also more likely to indi-
cate that they were able to regain a sense of normality. 
Most, but not all of these patients, thought that their 
medication was successful in helping them control 
symptoms and impacts. All but one had adopted some 
adaptation strategies and half described the positive 
influence of outside support. However, several patients 
who described mild disease did not convey a sense of a 
normal life. Most of these had been diagnosed relatively 
recently, related uncertainty about the effectiveness of 
their medication, were testing out adaptation strategies 
and were less likely to describe the positive influences of 
outside support.
Those patients that described moderate or severe 
disease activity, symptoms and impact, also frequently 
described a non-normal life. Again, several of these 
patients were recently diagnosed and were less certain 
about the effectiveness of medication in controlling 
disease activity and symptoms. Only one of these patients 
diagnosed over 10 years prior to interview detailed a 
long period of normality while medication controlled 
symptoms and prevented flare ups. More recently, 
with frequent flares, this patient described her life as a 
‘roller coaster’ with periods of severe disruption (flare 
ups) and intervening remission:
It is a bit like a rollercoaster, there’s like it can be 
relatively stable for a while, but a flare to me is when I 
start to lose blood and the urgency starts to creep up, 
and I find it difficult to like I say get out of the house 
in the morning and I have to use the toilet frequently 
at work, or if I’m out, and they’re specifically my flare 
up symptoms, and it’s usually always with passing 
blood as well, and like I said probably about three 
of those where I’ve been really bad over the past 12 
months. (Patient 3)
In contrast, four patients whom we interviewed, despite 
perceptions of more severe disease and flare ups, talked 
about life with UC in a manner concordant with regaining 
a sense of a normality. All but one had lived with UC for 
over 10 years and while they were unsure about the effec-
tiveness of their medication in controlling symptoms and 
flare ups, the use of adaptation strategies and descrip-
tions of positive outside support suggested that over time 
they had been able to adapt to a life accommodating UC. 
For example, Patient 19 adapted her working hours to be 
less tired:
I also changed my hours, when I had my [previous/
most severe] flare up  three years ago, I do 22 hours, 
and I used to do it in three days, so I would come in 
at half eight, and eight o’clock in the morning, and 
I wouldn’t finish until half four, I would have half an 
hour for lunch. After I was last ill it was easy for me 
to change my hours, and I do the same hours, but 
instead of doing it in three long days I do four short 
days, because for me it’s just easier, so then when I 
start to get tired I think well I’m going home mid-
afternoon, which is why I finish at half two, because 
it’s easier for me physically to cope with that, and 
mentally it’s much easier. (Patient 19)
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Another participant described how his wife had been 
key in providing emotional and practical support to help 
with adaptation:
I think the physical support, having somebody to lean 
on, you don’t realise it at the time when you’re on 
your own that you’ve just got… obviously got family 
around you but nobody directly in your life, in your 
house. I think just that moral and physical support 
there is a help, every little helps, it’s only a small 
percentage, it’s a definite help (Patient 26)
time
Participants’ accounts and descriptions of attempts to 
adapt to UC since diagnosis demonstrate that this is an 
iterative and ongoing process of trial and error. People 
test the boundaries of abilities and the role of adaptation 
methods and may take time to gain the necessary facilita-
tors to adaptation, and also to reach a point of acceptance 
of the disease or not. Similarly, the role of medical ther-
apies in improving physical well-being is often reported 
as being tested iteratively over time in collaboration with 
healthcare professionals. Finally, circumstances may 
change over time, such as the frequency and severity of 
flares.
DIscussIOn
To our knowledge, this is the first article in UC and the IBD 
sphere to propose a framework of normality (figure 1) to 
categorise and understand patients’ overall experience 
of life with the disease, and the factors that influence 
adaptation to it. The concept of disease-related normality 
helps us to think about how disease impacts on patients 
holistically; the interplay of physical symptoms; the conse-
quences for daily life and how patients see themselves 
and their lives as a result. It shows how disease can be 
a disrupting life experience (the ‘non-normal life’), and 
how patients approach adaptation and whether, broadly 
speaking, they are successful in this (the ‘normal-life’). In 
the absence of cure, disease symptoms, adaptation strate-
gies and outside support cumulate to influence patients’ 
views on life with the disease. This can change over time, 
with acceptance of the disease and need to adapt, and 
with changing circumstances, such as treatment, disease 
progression and the presence or absence of outside 
support.
For patients with UC to be able to live a ‘normal 
life’, traditional medical management is likely to be 
important but as highlighted in this sample, may 
be insufficient on its own. The majority of patients 
described other adaptation methods that they felt were 
required, that they had tried and tested or were in the 
process of testing. These methods aimed to achieve 
different but interrelated things; physical and psycho-
logical well-being; the ability to carry on working and 
to prevent embarrassment. There may not be good 
evidence that the aims of the adaptation strategies can 
be achieved by the specific methods adopted by patients. 
As we have described, patients themselves often actively 
reflect on the efficacy of their actions, for example, in 
monitoring and adjusting diet to influence physical 
well-being. Despite this, the trial and error adoption of 
different strategies may in itself be important as part of 
a process of accommodating disease and being active in 
doing so. Research in diabetes29 has proposed that such 
actions are important for young people in attempting 
to ‘master’ their disease, and recent research around 
normality in cancer survivorship30 has also indicated 
that the act of doing things is important in its own right 
regardless of the outcome of the action itself.
It was also clear that adaptation and normality were 
specific to the individual, meaning different things to 
different people. Reformulating identity and sense of 
self with disease is crucial for adaptation. Loss of sense 
of self has been identified as integral to chronic disease 
experience generally,31 and other researchers interested 
in normality in IBD have also observed that identity 
influences views on normality.9 15 17 For a normal life 
to be achieved, the disease and its impacts have to be 
accommodated via adaptation, and thereby integrated 
into a new, and perhaps dynamic, sense of self. We did 
not talk to anyone with UC who described their life as 
being the same as before the onset of disease. However, 
for many, the physical burden of disease will preclude 
this adaptation and for others there may be a significant 
period of time before adaptation is achieved.
The in-depth participant-focused qualitative research 
approach used here has allowed us to gather and analyse 
rich and detailed accounts of patients’ perspectives on 
living with and adapting to UC. We have talked to a 
range of patients who have lived with UC for varying 
periods of time. There are, however, limitations to our 
approach. All of the patients interviewed were partici-
pating in a pilot trial and as such the range of patients 
was influenced by the trial eligibility criteria. This 
meant, for example, that everybody was in remission at 
the time of the interview. Those with long-standing mild 
and controlled disease were less likely to figure in this 
research as patients had to have had a relapse within the 
12 months preceding recruitment. However, these are 
potentially the patients most likely to be able to adapt. 
Additionally, this research is cross-sectional in nature 
and so we have not been able to observe the temporal 
components of adaptation over time, although we have 
interviewed patients who have been diagnosed with UC 
between 1 and 22 years. Further research with a broader 
range of patients and perhaps with a longitudinal design 
may provide further insight.
Several patients commented that they had welcomed 
the opportunity to talk about their views in-depth to 
someone outside of the clinical team. A few of them 
said that they felt that their clinicians were not always 
receptive to the broader context that they were able to 
talk about as participants in this research. The implica-
tions of this for clinical practice need to be explored 
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further. Naturally, clinicians may focus on the phys-
ical and clinical manifestation of disease. As described 
here, physical well-being is a core component of adap-
tation and a ‘normal life’. However, physical disease 
and its impacts are experienced holistically by patients 
and those around them. The efficacy of medical and 
surgical management and patients’ relationship to this, 
for example, via adherence, shared decision-making 
re-treatment options, and interactions with healthcare 
professionals and services, will be judged by patients 
within the broader context of adaptation that we have 
described here. Other authors have recently reflected 
on the need to identify and address poor adaptation 
to IBD as a means to impact on quality of life and also 
potentially the course of disease.32 The consideration 
and development of interventions that facilitate adapta-
tion and self-management in UC may help to reflect the 
holistic experience and priorities of patients with UC.
cOnclusIOn
In this study, we have described the views of patients, who 
for the most part did not use biologics, on the factors 
that influence their adaptation to UC and whether they 
perceived that they are able to regain and maintain a 
‘normal life’. We have shown that adaptation to UC is 
complex and that medication alone is most often insuffi-
cient to achieve this. Symptoms, adaptation strategies and 
outside support all have an influence on whether patients 
manage to regain and maintain normality over time. This 
holistic view of adaptation to UC will help clinicians and 
researchers to understand patients’ views on life with 
the disease and the role of medical and other therapies 
within this.
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